References
-
1) Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway.
Product: ADIPOR2 Antibody (#DF12811)Year: 2022Journal: INT J BIOL SCIImpactFactor: 9.2DOI: 10.7150/ijbs.68873PMID: 35280674 -
2) Targeting transient receptor potential canonical 1 reduces non‑small cell lung cancer chemoresistance and stemness via inhibition of PI3K/AKT signaling.
Product: TRPC1 Antibody (#DF12783)Year: 2023Journal: Oncol LettImpactFactor: 2.9DOI: 10.3892/ol.2023.13810PMID: 37153044 -
3) HDAC1 regulates inflammation and osteogenic differentiation of ankylosing spondylitis fibroblasts through the Wnt-Smad signaling pathway.
Product: TRPC1 Antibody (#DF12783)Year: 2022Journal: J ORTHOP SURG RESImpactFactor: 2.6DOI: 10.1186/s13018-022-03224-zPMID: 35794630 -
4) miR-363-3p inhibits rat lung alveolar type II cell proliferation by downregulating STRA6 expression and induces cell apoptosis via cellular oxidative stress and G1-phase cell cycle arrest.
Product: STRA6 Antibody (#DF12756)Year: 2021Journal: TRANSL PEDIATRImpactFactor: 2DOI: 10.21037/tp-21-303PMID: 34584880 -
5) Notoginsenoside R1 Ameliorates Cardiac Lipotoxicity Through AMPK Signaling Pathway.
Product: SPTLC1 Antibody (#DF12752)Year: 2022Journal: FRONT PHARMACOLImpactFactor: 5.6DOI: 10.3389/fphar.2022.864326PMID: 35370720 -
6) SPRR3, a novel miR‑338‑3p target, regulates the malignant progression of clear cell renal cell carcinoma in vitro via the PI3K/Akt signaling pathway.
Product: SPRR3 Antibody (#DF12751)Year: 2022Journal: EXP THER MEDImpactFactor: 2.7DOI: 10.3892/etm.2022.11246PMID: 35350667 -
7) mTOR deletion ameliorates CD4+ T cell apoptosis during sepsis by improving autophagosome-lysosome fusion.
Product: SNAP29 Antibody (#DF12743)Year: 2022Journal: APOPTOSISImpactFactor: 7.2DOI: 10.1007/s10495-022-01719-yPMID: 35435531 -
8) Improving Lipophagy by Restoring Rab7 Cycle: Protective Effects of Quercetin on Ethanol-Induced Liver Steatosis.
Product: SNAP29 Antibody (#DF12743)Year: 2022Journal: NutrientsImpactFactor: 5.9DOI: 10.3390/nu14030658PMID: 35277017 -
9) Combination of resolvin E1 and lipoxin A4 promotes the resolution of pulpitis by inhibiting NF-κB activation through upregulating sirtuin 7 in dental pulp fibroblasts.
Product: SIRT6 Antibody (#DF12739)Year: 2022Journal: CELL PROLIFERATImpactFactor: 8.5DOI: 10.1111/cpr.13227PMID: 35411569 -
10) Differential Gene Expression Profiling in Alveolar Echinococcosis Identifies Potential Biomarkers Associated With Angiogenesis.
Product: RSPO3 Antibody (#DF12728)Year: 2023Journal: OPEN FORUM INFECT DIImpactFactor: 4.2DOI: 10.1093/ofid/ofad031PMID: 36817746 -
11) YY1 complex promotes Quaking expression via super-enhancer binding during EMT of hepatocellular carcinoma.
Product: QKI Antibody (#DF12715)Year: 2019Journal: CANCER RESImpactFactor: 11.2DOI: 10.1158/0008-5472.CAN-18-2238PMID: 30760518 -
12) Serine Metabolism Regulates the Replicative Senescence of Human Dental Pulp Cells through Histone Methylation.
Product: PSPH Antibody (#DF12711)Year: 2024Journal: Curr Issues Mol BiolImpactFactor: 3.1DOI: 10.3390/cimb46040179PMID: 38666909 -
13) Cardioprotective role of A-cycloglycosylated derivative of Rubiadin in diabetic cardiomyopathy in rats.
Product: PP5 Antibody (#DF12706)Year: 2023Journal: Int ImmunopharmacolImpactFactor: 5.6DOI: 10.1016/j.intimp.2023.110008PMID: 36989899 -
14) A novel splice site variant in the POPDC3 causes autosomal recessive limb‐girdle muscular dystrophy type 26.
Product: POPDC3 Antibody (#DF12702)Year: 2022Journal: CLIN GENETImpactFactor: 3.5DOI: 10.1111/cge.14192PMID: 35842834 -
15) Systems pharmacology reveals the mechanism of Astragaloside IV in improving immune activity on cyclophosphamide-induced immunosuppressed mice.
Product: PHD3 Antibody (#DF12694)Year: 2023Journal: J ETHNOPHARMACOLImpactFactor: 5.4DOI: 10.1016/j.jep.2023.116533